12-Month Outcomes of Goniotomy Performed Using the Kahook Dual Blade Combined with Cataract Surgery in Eyes with Medically Treated Glaucoma
Syril K Dorairaj, Leonard K Seibold, Nathan M Radcliffe, Ahmad A Aref, Jesús Jimenez-Román, Gabriel S Lazcano-Gomez, Jason K Darlington, Kaweh Mansouri, John P Berdahl, Syril K Dorairaj, Leonard K Seibold, Nathan M Radcliffe, Ahmad A Aref, Jesús Jimenez-Román, Gabriel S Lazcano-Gomez, Jason K Darlington, Kaweh Mansouri, John P Berdahl
Abstract
Introduction: To describe the 12-month efficacy and safety of goniotomy performed using the Kahook Dual Blade (KDB) in combination with cataract surgery in eyes with medically treated open-angle glaucoma (OAG).
Methods: This was a prospective, interventional case series conducted at seven centers in North America. Consecutive patients with medically treated OAG and visually significant cataract underwent phacoemulsification combined with goniotomy (PE + goniotomy) using KDB. Indications for glaucoma surgery included reduction of intraocular pressure (IOP) and reduction of IOP-lowering medications. De-identified data were collected and included pre-, intra-, and postoperative data on IOP, the use of IOP-lowering medications, and adverse events through 12 months of follow-up.
Results: Among 52 eyes undergoing surgery, mean IOP was reduced from 16.8 ± 0.6 mmHg at baseline to 12.4 ± 0.3 mmHg at month 12 (P < 0.001), a 26.2% reduction. Mean IOP across time points ranged from 12.4-13.3 mmHg during follow-up. The mean number of topical IOP-lowering medications was reduced from 1.6 ± 0.2 at baseline to 0.8 ± 0.1 at month 12 (P < 0.05), a 50.0% reduction. At month 12, 57.7% of eyes had IOP reduction ≥ 20% from baseline, and 63.5% were on ≥ 1 fewer IOP-lowering medications. In subgroup analysis, 84.6% of eyes with lower mean baseline IOP were using ≥ 1 fewer medications at month 12, and 100% of eyes with higher mean baseline IOP had IOP reductions ≥ 20%. The most common postoperative adverse events were pain/irritation (n = 4, 7.7%), opacification of the posterior lens capsule (n = 2, 3.8%), and IOP spike > 10 mmHg (n = 2, 3.8%).
Conclusion: PE + goniotomy using the KDB significantly lowers both IOP and dependence on IOP-lowering medications in eyes with OAG. Adverse events were not sight-threatening and typically resolved spontaneously.
Funding: New World Medical, Inc.
Keywords: Cataract surgery; Glaucoma; Goniotomy; Intraocular pressure; Micro-incisional glaucoma surgery; Micro-invasive glaucoma surgery; Ophthalmology; Phacoemulsification; Trabecular meshwork.
Figures
References
- AGIS Study Group The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology. 1998;105:1146–1164. doi: 10.1016/S0161-6420(98)97013-0.
- Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953. doi: 10.1016/S0161-6420(01)00873-9.
- Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol. 1988;72:881–889. doi: 10.1136/bjo.72.12.881.
- Migdal C, Hitchings R. Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Trans Ophthalmol Soc UK. 1986;105(Pt 6):653–656.
- DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297–300. doi: 10.1001/archopht.120.3.297.
- SooHoo JR, Seibold LK, Radcliffe NM, Kahook MY. Minimally invasive glaucoma surgery: current implants and future innovations. Can J Ophthalmol. 2014;49:528–533. doi: 10.1016/j.jcjo.2014.09.002.
- Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189–206.
- Sheybani A, Dick HB, Ahmed II. Early clinical results of a novel ab interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma. 2016;25:e691–e696. doi: 10.1097/IJG.0000000000000352.
- Batlle JF, Fantes F, Riss I, et al. Three-year follow-up of a novel aqueous humor microshunt. J Glaucoma. 2016;25:e58–e65. doi: 10.1097/IJG.0000000000000368.
- Francis BA, Akil H, Bert BB. Ab interno Schlemm’s canal surgery. Dev Ophthalmol. 2017;59:127–146. doi: 10.1159/000458492.
- Khouri AS, Wong SH. Ab interno trabeculectomy with a dual blade: surgical technique for childhood glaucoma. J Glaucoma. 2017;26:749–751. doi: 10.1097/IJG.0000000000000701.
- Seibold LK, Soohoo JR, Ammar DA, Kahook MY. Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device. Am J Ophthalmol. 2013;155(524–9):e2.
- Greenwood MD, Seibold LK, Radcliffe N, et al. Goniotomy with a single-use dual blade: short-term results. J Cataract Refract Surg. 2017;43(9):1197–1201. doi: 10.1016/j.jcrs.2017.06.046.
- Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459–467. doi: 10.1016/j.ophtha.2010.07.007.
- Vold S, Ahmed II, Craven ER, et al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123:2103–2112. doi: 10.1016/j.ophtha.2016.06.032.
- Minckler DS, Baerveldt G, Alfaro MR, Francis BA. Clinical results with the trabectome for treatment of open-angle glaucoma. Ophthalmology. 2005;112:962–967. doi: 10.1016/j.ophtha.2004.12.043.
- Quaranta L, Hitchings RA, Quaranta CA. Ab-interno goniotrabeculotomy versus mitomycin C trabeculectomy for adult open-angle glaucoma: a 2-year randomized clinical trial. Ophthalmology. 1999;106:1357–1362. doi: 10.1016/S0161-6420(99)00725-3.
- Armstrong JJ, Wasiuta T, Kiatos E, Malvankar-Mehta M, Hutnik CM. The effects of phacoemulsification on intraocular pressure and topical medication use in patients with glaucoma: a systematic review and meta-analysis of 3-year data. J Glaucoma. 2017;26:511–522. doi: 10.1097/IJG.0000000000000643.
Source: PubMed